Velan (VLN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
24 Nov, 2025Executive summary
Fiscal 2025 sales grew 14.1% to $295.2 million, with gross profit margin up 770 basis points to 28.8%.
Adjusted EBITDA surged to $27.5 million from $2.1 million last year, and cash flow from operations more than doubled to $26.5 million.
Major strategic actions included the sale of French subsidiaries for $208 million and divestiture of asbestos-related liabilities for $143 million, significantly strengthening the balance sheet and reducing risk.
Special dividend of CA$0.30 per share was declared, in addition to the regular dividend, returning proceeds from recent transactions.
Pro forma cash position post-transactions is $55 million, supporting future investments.
Financial highlights
Fiscal 2025 sales rose 14.1% to $295.2 million, driven by strong performance in oil and gas, German, and Italian operations.
Gross profit increased to $84.9 million, with margin up to 28.8%.
Adjusted net income was $6.6 million, a turnaround from a $15.7 million loss in 2020.
Q4 sales were $83.2 million, up 2.9% year-over-year, but Q4 adjusted EBITDA fell to $3.6 million due to lower gross margin and higher admin costs.
Cash and equivalents at year-end were $34.9 million; pro forma cash post-transactions is $55 million.
Outlook and guidance
Anticipates acceleration in nuclear orders and a shift in backlog toward longer-term projects.
Expects continued strong demand in energy, especially nuclear, and growth in defense, LNG, hydrogen, and mining sectors.
82% of the $274.9 million backlog is expected to be delivered within 12 months.
Management expects another solid performance in fiscal 2026, supported by a sharpened focus and improved balance sheet.
Latest events from Velan
- Bookings and backlog improved, supporting growth and cash flow focus for 2025.VLN
AGM 20243 Feb 2026 - Q1 sales up 14.5%, gross margin 30.7%, backlog $528.3M, and major nuclear deal signed.VLN
Q1 20253 Feb 2026 - Bookings and sales soared, backlog reached $548.1M, and net income turned positive.VLN
Q2 202519 Jan 2026 - Strong backlog, major asset sale, and ownership transition marked Q3 2026.VLN
Q3 202615 Jan 2026 - Q3 saw 18.1% sales growth, margin gains, and risk reduction from major divestitures.VLN
Q3 202510 Jan 2026 - Shareholders approved the $201.1 million sale of French subsidiaries to Framatome.VLN
EGM 202526 Dec 2025 - 18.6% sales growth, margin gains, and record cash drive a higher dividend and strong outlook.VLN
Q1 202616 Nov 2025 - Strong growth, risk reduction, and strategic expansion defined the year, with all motions approved.VLN
AGM 202516 Nov 2025 - Q2 sales fell 13%, but backlog and liquidity rose, supporting growth in key sectors.VLN
Q2 202612 Oct 2025